Treatment of Rhodesian sleeping sickness in Kenya.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Annals of Tropical Medicine and Parasitology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1080/00034983.1989.11812413PMID 2619399
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• New WHO guidelines for treating rhodesiense human African trypanosomiasis: expanded indications for fexinidazole and pentamidine.

  2024cites this paper
• Drug Resistance in African Trypanosomiasis

  2009cites this paper
• Human African Trypanosomiasis

  2009cites this paper
• Thèse en co-tutelle Pour obtenir le grade de DOCTEUR DE L'UNIVERSITE DE LIMOGES Discipline : Biologie-Science-Santé Spécialité : Parasitologie

  2008cites this paper
• Apports diagnostiques au cours de la trypanosomose humaine africaine

  2008cites this paper
• Epidemiology of vector-borne diseases in cattle from SE Uganda.

  2006cites this paper
• LA TRIPANOSOMOSI HUMANA AFRICANA AL FOCUS HISTÒRIC DE QUIÇAMA, ANGOLA

  2005cites this paper
• History of U.S. military contributions to the study of parasitic diseases.

  2005cites this paper
• Treatment perspectives for human African trypanosomiasis

  2003cites this paper
• An automated biological assay to determine levels of the trypanocidal drug melarsoprol in biological fluids.

  2000cites this paper
• Animal Models of Acute (first-stage) Sleeping Sickness

  1999cites this paper
• Present strategies in the treatment of human African trypanosomiasis

  1999cites this paper
• Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.

  1996cites this paper
• Topical Review: Parasitic Infections of the Central Nervous System in Children. Part I: Congenital Infections and Meningoencephalitis

  1995cites this paper
• Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.

  1995cites this paper
• Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness.

  1995cites this paper
• Innate lack of susceptibility of Ugandan Trypanosoma brucei rhodesiense to DL-alpha-difluoromethylornithine (DFMO).

  1995cites this paper
• Gambiense trypanosomiasis: frequency of, and risk factors for, failure of melarsoprol therapy.

  1994cites this paper
• The treatment of human African trypanosomiasis.

  1994cites this paper
• Drug used in the treatment of sleeping sickness (human African trypanosomiasis: HAT).

  1994cites this paper
• Pharmacokinetics of melarsoprol in uninfected vervet monkeys.

  1994cites this paper
• Immunoassay of circulating trypanosomal antigens in sleeping sickness patients undergoing treatment.

  1994cites this paper
• Pharmacokinetic properties of the trypanocidal drug melarsoprol.

  1993cites this paper
• Evaluation of Procyclic Agglutination Trypanosomiasis Test (PATT) for the immunodiagnosis of Trypanosoma brucei rhodesiense sleeping sickness in Kenya.

  1992cites this paper
• Pharmacokinetic Justification of Antiprotozoal Therapy

  1991cites this paper